samedan logo
 
 
spacer
home > white papers > Working Towards a Standardised Identification Solution - PCI Pharma Services
WHITE PAPERS
logo_PCI_PharmaL.jpg

PCI Pharma Services

phone +44 (0)1495 713 633
email sales@pciservices.com
web http://www.pciservices.com
email Wye Valley Business Park, Hay-on-Wye, HR3 5PG

Working Towards a Standardised Identification Solution

The security of the pharmaceutical supply chain is an issue of growing concern, with recent reports addressing its vulnerability to counterfeiting. The complexity of the European supply chain is one of the key factors of this counterfeiting pandemic, with millions of medicine packs being moved around the EU, annually. Aside from this, fragmentation has resulted in decreased transparency in the
supply chain and increased difficulties to track and trace medicines, leading to significant threat from counterfeiting. As a key source of income for the European economy, it is essential that the supply chain remains safe and free of counterfeits. A significant stumbling block within the industry remains to be the lack of a unified, single‐source pan‐European or indeed global database where scanned bar codes on drug packaging can be verified at point of dispense. At some point in the future the pharmaceutical industry, regulatory bodies, clinicians and retailers will need to join forces to overcome this.
Working Towards a Standardised Identification Solution
spacer

Member login

E-mail address:

Password:
Remember me


News and Press Releases

New at CPhI Worldwide: Gerresheimer complements its primary packaging portfolio introducing ready-to-fill vials

Düsseldorf/Frankfurt October 24, 2017 ‒ In hall 4.2 at booth D02 at CPhl Worldwide in Frankfurt, Gerresheimer, a leading global manufacturer of primary packaging for the pharmaceutical industry is presenting the new Gx RTF vials. The customer can receive identically packaged sterile injection vials from two different manufacturers as Gerresheimer’s RTF vials will be delivered adopting Ompi EZ-fill® packaging process. 
More info >>


White Papers

R&D to Product: How to Reduce Costly Scale-Up Problems

Natoli Engineering Company, Inc.

When scaling a new drug formulation from the development side of R&D into manufacturing, there is often a reality check with respect to process scaleup and performance of the formulation at production levels. Problems with capping/lamination and sticking/ picking are often first realized when a formulation is introduced to a level of compression required to supply market demand.
More info >>


Industry Events

14th World Advanced Therapies & Regenerative Medicine Congress 2018

16-18 May 2018, Business Design Centre, London, United Kingdom

In May 2018 the World Advanced Therapies & Regenerative Medicine Congress, will bring together 800+ attendees and explore the rapidly developing world of ATMPs (Advanced Therapy Medicinal Products).
More info >>


©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement